Works matching Investigational therapies

Results: 1521
    1

    Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats.

    Published in:
    Veterinary & Comparative Oncology, 2021, v. 19, n. 2, p. 311, doi. 10.1111/vco.12677
    By:
    • LeBlanc, Amy K.;
    • Atherton, Matthew;
    • Bentley, R. Timothy;
    • Boudreau, C. Elizabeth;
    • Burton, Jenna H.;
    • Curran, Kaitlin M.;
    • Dow, Steven;
    • Giuffrida, Michelle A.;
    • Kellihan, Heidi B.;
    • Mason, Nicola J.;
    • Oblak, Michelle;
    • Selmic, Laura E.;
    • Selting, Kimberly A.;
    • Singh, Ameet;
    • Tjostheim, Sonja;
    • Vail, David M.;
    • Weishaar, Kristen M.;
    • Berger, Erika P.;
    • Rossmeisl, John H.;
    • Mazcko, Christina
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Investigational Therapies and Patients' Autonomy.

    Published in:
    Canadian Journal of Bioethics / Revue canadienne de bioéthique, 2020, v. 3, n. 3, p. 115, doi. 10.7202/1073786ar
    By:
    • Papakonstantinou, Trisevgeni;
    • Kolettis, Theofilos M.
    Publication type:
    Article
    13
    14

    Four cases of investigational therapy with interleukin-11 against acute myocardial infarction.

    Published in:
    Heart & Vessels, 2016, v. 31, n. 9, p. 1574, doi. 10.1007/s00380-015-0788-4
    By:
    • Nakagawa, Masashi;
    • Owada, Yasuko;
    • Izumi, Yasukatsu;
    • Nonin, Shinichi;
    • Sugioka, Kenichi;
    • Nakatani, Daisaku;
    • Iwata, Shinichi;
    • Mizutani, Kazuki;
    • Nishimura, Satoshi;
    • Ito, Asahiro;
    • Fujita, Suwako;
    • Daimon, Takashi;
    • Sawa, Yoshiki;
    • Asakura, Masanori;
    • Maeda, Makiko;
    • Fujio, Yasushi;
    • Yoshiyama, Minoru
    Publication type:
    Article
    15
    16
    17

    Corrigendum: First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP: TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.

    Published in:
    2025
    By:
    • Shimizu, Toshio;
    • Powderly, John;
    • Abdul Razak, Albiruni;
    • LoRusso, Patricia;
    • Miller, Kathy D.;
    • Kao, Steven;
    • Kongpachith, Sarah;
    • Tribouley, Catherine;
    • Graham, Michelle;
    • Stoll, Brian;
    • Patel, Maulik;
    • Sahtout, Mohammad;
    • Blaney, Martha;
    • Leibman, Rachel;
    • Golan, Talia;
    • Tolcher, Anthony
    Publication type:
    Correction Notice
    18

    First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.

    Published in:
    Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2024.1376551
    By:
    • Shimizu, Toshio;
    • Powderly, John;
    • Abdul Razak, Albiruni;
    • LoRusso, Patricia;
    • Miller, Kathy D.;
    • Kao, Steven;
    • Kongpachith, Sarah;
    • Tribouley, Catherine;
    • Graham, Michelle;
    • Stoll, Brian;
    • Patel, Maulik;
    • Sahtout, Mohammad;
    • Blaney, Martha;
    • Leibman, Rachel;
    • Golan, Talia;
    • Tolcher, Anthony
    Publication type:
    Article
    19

    First-in-human phase 1 dose-escalation results with livmoniplimab, an antibody targeting the GARP:TGF-ß1 complex, as monotherapy and in combination with the anti–PD-1 antibody budigalimab in patients with advanced solid tumors.

    Published in:
    Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1376551
    By:
    • Shimizu, Toshio;
    • Powderly, John;
    • Abdul Razak, Albiruni;
    • LoRusso, Patricia;
    • Miller, Kathy D.;
    • Kao, Steven;
    • Kongpachith, Sarah;
    • Tribouley, Catherine;
    • Graham, Michelle;
    • Stoll, Brian;
    • Patel, Maulik;
    • Sahtout, Mohammad;
    • Blaney, Martha;
    • Leibman, Rachel;
    • Golan, Talia;
    • Tolcher, Anthony
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26

    A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint.

    Published in:
    Clinical Epigenetics, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13148-021-01014-8
    By:
    • Bever, Katherine M.;
    • Thomas II, Dwayne L.;
    • Zhang, Jiajia;
    • Diaz Rivera, Ernie A.;
    • Rosner, Gary L.;
    • Zhu, Qingfeng;
    • Nauroth, Julie M.;
    • Christmas, Brian;
    • Thompson, Elizabeth D.;
    • Anders, Robert A.;
    • Judkins, Carol;
    • Liu, Meizheng;
    • Jaffee, Elizabeth M.;
    • Ahuja, Nita;
    • Zheng, Lei;
    • Azad, Nilofer S.
    Publication type:
    Article
    27
    28
    29
    30
    31

    Workshop summary: Potential usefulness and feasibility of a US National Mesothelioma Registry.

    Published in:
    American Journal of Industrial Medicine, 2020, v. 63, n. 2, p. 105, doi. 10.1002/ajim.23062
    By:
    • Cummings, Kristin J.;
    • Becich, Michael J.;
    • Blackley, David J.;
    • Deapen, Dennis;
    • Harrison, Robert;
    • Hassan, Raffit;
    • Henley, S. Jane;
    • Hesdorffer, Mary;
    • Horton, D. Kevin;
    • Mazurek, Jacek M.;
    • Pass, Harvey I.;
    • Taioli, Emanuela;
    • Wu, Xiao‐Cheng;
    • Zauderer, Marjorie G.;
    • Weissman, David N.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    The role of emerging and investigational therapies for metastatic brain tumors: a systematic review and evidence-based clinical practice guideline of selected topics.

    Published in:
    Journal of Neuro-Oncology, 2010, v. 96, n. 1, p. 115, doi. 10.1007/s11060-009-0058-3
    By:
    • Olson, Jeffrey;
    • Paleologos, Nina;
    • Gaspar, Laurie;
    • Robinson, Paula;
    • Morris, Rachel;
    • Ammirati, Mario;
    • Andrews, David;
    • Asher, Anthony;
    • Burri, Stuart;
    • Cobbs, Charles;
    • Kondziolka, Douglas;
    • Linskey, Mark;
    • Loeffler, Jay;
    • McDermott, Michael;
    • Mehta, Minesh;
    • Mikkelsen, Tom;
    • Patchell, Roy;
    • Ryken, Timothy;
    • Kalkanis, Steven
    Publication type:
    Article
    43
    44
    45
    46

    HBV and HDV: New Treatments on the Horizon.

    Published in:
    Journal of Clinical Medicine, 2021, v. 10, n. 18, p. 4054, doi. 10.3390/jcm10184054
    By:
    • Zuccaro, Valentina;
    • Asperges, Erika;
    • Colaneri, Marta;
    • Marvulli, Lea Nadia;
    • Bruno, Raffaele
    Publication type:
    Article
    47

    Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11493-2
    By:
    • Reitman, Zachary J.;
    • Paolella, Brenton R.;
    • Bergthold, Guillaume;
    • Pelton, Kristine;
    • Becker, Sarah;
    • Jones, Robert;
    • Sinai, Claire E.;
    • Malkin, Hayley;
    • Huang, Ying;
    • Grimmet, Leslie;
    • Herbert, Zachary T.;
    • Sun, Yu;
    • Weatherbee, Jessica L.;
    • Alberta, John A.;
    • Daley, John F.;
    • Rozenblatt-Rosen, Orit;
    • Condurat, Alexandra L.;
    • Qian, Kenin;
    • Khadka, Prasidda;
    • Segal, Rosalind A.
    Publication type:
    Article
    48

    Current status and research directions in acute myeloid leukemia.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01143-2
    By:
    • Kantarjian, Hagop;
    • Borthakur, Gautam;
    • Daver, Naval;
    • DiNardo, Courtney D.;
    • Issa, Ghayas;
    • Jabbour, Elias;
    • Kadia, Tapan;
    • Sasaki, Koji;
    • Short, Nicholas J.;
    • Yilmaz, Musa;
    • Ravandi, Farhad
    Publication type:
    Article
    49
    50